ProSomnus SPAC Presentation Deck
Significant Growth Potential and Attractive Financial Prospects
CAGR
NET REVENUE (2020A - 2023E)
($ in millions)
$8
2020A
Growth Rate
50%
GROSS MARGIN (2020A - 2023E)
($ in millions)
2020A
$14
~400 basis point impact due to supply chain
disruptions
Adj. EBITDA Margin
2021A
Unlevered Free Cash Flow¹
70%
52%
2021A
(25%)
($3)
~70%
$20-21
2022E
~45%
Q1 '22
Gross Margin
~58%
~59%
2022E
~(15%)
~($6)
$38-40
2023E
~90%
~65%
2023E
~(5%)
~($6)
KEY REVENUE DRIVERS
PROSOMNUS
SLEEP TECHNOLOGIES
▪ North America direct sales rep expansion from 8 in 2021 to
>20 in 2023
▪ Expansion into international markets, and hiring of direct
sales reps in Europe
▪ DTC advertising to drive patient awareness and clinician
education to ProSomnus Oral appliance benefits
■ Additional revenue stream associated with Remote Patient
Monitoring capabilities in pipeline product (expected soft
launch in Q4 '22)
KEY GROSS MARGIN DRIVERS
■ Product mix shifting to higher margin EVO and RPM related
revenue
▪ Software upgrades, automation and process improvement
initiatives are aimed at lowering direct material and direct
labor costs
■ Transition of manufacturing to a lower cost jurisdiction
expected to provide significant margin improvement related
to direct labor
■ Purchasing scale and volume discounts anticipated to lower
direct material costs
■ Economies of scale expected to drive lower overhead as a %
of revenue
Note: ProSomnus previously disclosed to certain parties certain financial prospects for calendar years ending 2024 and 2025. These financial prospects included 2024 and 2025 revenue of $70-74M and $120-125M, respectively;
2024 and 2025 gross margin of ~68% and ~70%, respectively; 2024 and 2025 Adj. EBITDA margin of ~3% and ~14%, respectively; and 2024 and 2025 unlevered free cash flow of ($5M) and $5M, respectively. ProSomnus is no
longer issuing guidance for its financial prospects in 2024 and 2025.
1. Unlevered Free Cash Flow defined as Cash Flow from Operations (unlevered) less Cash Flow from Investing less Equipment Lease Financing. Does not include transaction costs.
22
STRICTLY CONFIDENTIALView entire presentation